Anders Friberg
Bayer (Germany)(DE)
Publications by Year
Research Areas
Cancer Mechanisms and Therapy, Protein Kinase Regulation and GTPase Signaling, Melanoma and MAPK Pathways, Synthesis and biological activity, Chemical Synthesis and Analysis
Most-Cited Works
- → Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design(2012)303 cited
- → The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies(2019)239 cited
- → Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods(2016)144 cited
- → Discovery of Tricyclic Indoles That Potently Inhibit Mcl-1 Using Fragment-Based Methods and Structure-Based Design(2015)95 cited
- → Structure and Ligand Binding of the Extended Tudor Domain of D. melanogaster Tudor-SN(2009)64 cited
- → Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function(2006)49 cited
- → Structural Evidence for Isoform-Selective Allosteric Inhibition of Lactate Dehydrogenase A(2020)42 cited
- → A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand(2014)40 cited
- → Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRASG12C(2020)34 cited
- → Oral Disinfectants Inhibit Protein–Protein Interactions Mediated by the Anti‐Apoptotic Protein Bcl‐xL and Induce Apoptosis in Human Oral Tumor Cells(2013)21 cited